Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Bart G Jones"'
Autor:
Christina M. Kackos, Sherri L. Surman, Bart G. Jones, Robert E. Sealy, Trushar Jeevan, Christopher J. H. Davitt, Sergei Pustylnikov, Tamarand L. Darling, Adrianus C. M. Boon, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in December of 2019 and is responsible for millions of infections and deaths across the globe. Vaccination against SARS-CoV-2 has proven effe
Externí odkaz:
https://doaj.org/article/4e606723ff53413194b0c6a9be5ac4ad
Autor:
Felicia Scaggs Huang, David I. Bernstein, Karen S. Slobod, Allen Portner, Toru Takimoto, Charles J. Russell, Michael Meagher, Bart G. Jones, Robert E. Sealy, Christopher Coleclough, Kristen Branum, Michelle Dickey, Kristen Buschle, Monica McNeal, Mat Makowski, Aya Nakamura, Julia L. Hurwitz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 2, Pp 554-559 (2021)
SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vac
Externí odkaz:
https://doaj.org/article/0024b08a41a0453eab429c20987a46a3
Autor:
Sherri L. Surman, Bart G. Jones, Rhiannon R. Penkert, Robert E. Sealy, Tony Marion, Paul G. Thomas, Geoffrey Neale, Beisi Xu, Julia L. Hurwitz
Publikováno v:
Viruses, Vol 15, Iss 2, p 482 (2023)
Females often exhibit superior immune responses compared to males toward vaccines and pathogens such as influenza viruses and SARS-CoV-2. To help explain these differences, we first studied serum immunoglobulin isotype patterns in C57BL/6 male and fe
Externí odkaz:
https://doaj.org/article/78738e4b068044f3aed4eafd16a6833c
Autor:
Nehali Patel, Rhiannon R. Penkert, Robert E. Sealy, Sherri L. Surman, Bart G. Jones, Karen Ringwald-Smith, A. Catharine Ross, Julia L. Hurwitz
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2322 (2022)
Healthy pediatric immune responses depend on adequate vitamin A and D levels. Relationships between solar ultraviolet B (UVB) radiation and vitamin D are well understood, while relationships between sunlight, vitamin A, and its serum escort, retinol
Externí odkaz:
https://doaj.org/article/e4b63a4901e84de4ae67995e4cd4012d
Autor:
Rhiannon R. Penkert, Melissa Azul, Robert E. Sealy, Bart G. Jones, Jola Dowdy, Randall T. Hayden, Li Tang, A. Catharine Ross, Jane S. Hankins, Julia L. Hurwitz
Publikováno v:
Nutrients; Volume 14; Issue 16; Pages: 3415
Human parvovirus B19 causes life-threatening anemia due to transient red cell aplasia (TRCA) in individuals with sickle cell disease (SCD). Children with SCD experiencing profound anemia during TRCA often require red blood cell transfusions and hospi
Autor:
Nehali Patel, Rhiannon R. Penkert, Bart G. Jones, Robert E. Sealy, Sherri L. Surman, Yilun Sun, Li Tang, Jennifer DeBeauchamp, Ashley Webb, Julie Richardson, Ryan Heine, Ronald H. Dallas, A. Catharine Ross, Richard Webby, Julia L. Hurwitz
Publikováno v:
Viruses, Vol 11, Iss 10, p 907 (2019)
Maximizing vaccine efficacy is critical, but previous research has failed to provide a one-size-fits-all solution. Although vitamin A and vitamin D supplementation studies have been designed to improve vaccine efficacy, experimental results have been
Externí odkaz:
https://doaj.org/article/8cd1bc12c45f49d5a6624b993e36b527
Autor:
Robert E. Sealy, Bart G. Jones, Sherri L. Surman, Rhiannon R. Penkert, Stephane Pelletier, Geoff Neale, Julia L. Hurwitz
Publikováno v:
Vaccines, Vol 7, Iss 1, p 26 (2019)
Despite extraordinary advances in fields of immunology and infectious diseases, vaccine development remains a challenge. The development of a respiratory syncytial virus vaccine, for example, has spanned more than 50 years of research with studies of
Externí odkaz:
https://doaj.org/article/811776c87294438fbc9633779108f11a
Publikováno v:
Viruses, Vol 5, Iss 2, Pp 577-594 (2013)
Respiratory syncytial virus (RSV) is the etiological agent for a serious lower respiratory tract disease responsible for close to 200,000 annual deaths worldwide. The first infection is generally most severe, while re-infections usually associate wit
Externí odkaz:
https://doaj.org/article/c1ac74d207674357bc9b5b1b2353e606
Autor:
Victoria A Meliopoulos, Lee-Ann Van de Velde, Nicholas C Van de Velde, Erik A Karlsson, Geoff Neale, Peter Vogel, Cliff Guy, Shalini Sharma, Susu Duan, Sherri L Surman, Bart G Jones, Michael D L Johnson, Catharine Bosio, Lisa Jolly, R Gisli Jenkins, Julia L Hurwitz, Jason W Rosch, Dean Sheppard, Paul G Thomas, Peter J Murray, Stacey Schultz-Cherry
Publikováno v:
PLoS Pathogens, Vol 12, Iss 8, p e1005804 (2016)
The healthy lung maintains a steady state of immune readiness to rapidly respond to injury from invaders. Integrins are important for setting the parameters of this resting state, particularly the epithelial-restricted αVβ6 integrin, which is upreg
Externí odkaz:
https://doaj.org/article/34b3f00131f54876a1d6645d45e12018
Autor:
Toru Takimoto, Felicia Scaggs Huang, Michelle Dickey, Karen S. Slobod, David I. Bernstein, Allen Portner, Aya Nakamura, Bart G. Jones, Mat Makowski, Charles J. Russell, Christopher Coleclough, Julia L. Hurwitz, Kristen N Buschle, Kristen Branum, Robert E. Sealy, Michael M Meagher, Monica M. McNeal
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vac